Z. Hao

发表

Improved synthesis of zebularine [1-(beta-D-ribofuranosyl)-dihydropyrimidin-2-one] nucleotides as inhibitors of human deoxycytidylate deaminase.

Z. Weinberg, V. Marquez, J. Barchi, 1995, Journal of enzyme inhibition.

Cellular pharmacology of cyclopentenyl cytosine in Molt-4 lymphoblasts.

J. Tomaszewski, D. Cooney, D. Johns, 1991, Cancer research.

Reversal by cytidine of cyclopentenyl cytosine-induced toxicity in mice without compromise of antitumor activity.

J. Plowman, W. Waud, J. Driscoll, 1995, Biochemical pharmacology.

Intracellular metabolism and mechanism of anti-retrovirus action of 9-(2-phosphonylmethoxyethyl)adenine, a potent anti-human immunodeficiency virus compound.

E. De Clercq, P. Herdewijn, J. Balzarini, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Metabolism and action of amino acid analog anti-cancer agents.

J. Grem, D. Cooney, Z. Hao, 1990, Pharmacology & therapeutics.

Factors determining the activity of 2',3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitro.

S. Broder, C. Perno, M. Sarngadharan, 1988, Molecular pharmacology.

Long-term erythropoietin expression in rodents and non-human primates following intramuscular injection of a replication-defective adenoviral vector.

E. Svensson, J. Leiden, E. Goldwasser, 1997, Human gene therapy.

Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido- 2'3'-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine

D. S. Webb, H. Mitsuya, S. Broder, 1989, The Journal of experimental medicine.

Arsenic trioxide inhibits proliferation in K562 cells by changing cell cycle and survivin expression

Z. Ping, Z. Hao, You Yong, 2008, Journal of Huazhong University of Science and Technology [Medical Sciences].

Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'- dideoxynucleosides

S. Broder, C. Perno, R. Yarchoan, 1988, The Journal of experimental medicine.

Initial studies on the cellular pharmacology of 2',3'-dideoxyinosine, an inhibitor of HIV infectivity.

S. Broder, D. Cooney, A. Fridland, 1987, Biochemical pharmacology.

Initial studies on the cellular pharmacology of 2',3-dideoxycytidine, an inhibitor of HTLV-III infectivity.

S. Broder, J. Balzarini, D. Cooney, 1986, Biochemical pharmacology.

Carbocyclic analogues of the potent cytidine deaminase inhibitor 1-(beta-D-ribofuranosyl)-1,2-dihydropyrimidin-2-one (zebularine).

L. Jeong, V. Marquez, D. Cooney, 1998, Journal of medicinal chemistry.

2'-Fluoro-2',3'-dideoxyarabinosyladenine: a metabolically stable analogue of the antiretroviral agent 2',3'-dideoxyadenosine.

H. Mitsuya, S. Broder, C. Perno, 1990, Molecular pharmacology.

Potent DNA chain termination activity and selective inhibition of human immunodeficiency virus reverse transcriptase by 2',3'-dideoxyuridine-5'-triphosphate.

J. Balzarini, C. Perno, D. Farquhar, 1990, Molecular pharmacology.

Comparison of biochemical parameters of benzamide riboside, a new inhibitor of IMP dehydrogenase, with tiazofurin and selenazofurin.

K. Paull, T. Szekeres, K. Krohn, 1994, Biochemical pharmacology.

Biosynthetic ganciclovir triphosphate: its isolation and characterization from ganciclovir-treated herpes simplex thymidine kinase-transduced murine cells.

F. Candotti, R. Blaese, R. Agbaria, 2001, Biochemical and biophysical research communications.

Effects of IMP dehydrogenase inhibitors on the phosphorylation of ganciclovir in MOLT-4 cells before and after herpes simplex virus thymidine kinase gene transduction.

R. Blaese, R. Agbaria, C. Mullen, 1994, Molecular pharmacology.

Inhibition of EZH2 expression is associated with the proliferation, apoptosis and migration of SW620 colorectal cancer cells in vitro.

W. Liang, Z. Jian, Xiao-Dong Yang, 2015, Experimental biology and medicine.

A potent oncolytic adenovirus selectively blocks the STAT3 signaling pathway and potentiates cisplatin antitumor activity in ovarian cancer.

Daowen Wang, D. Ma, Peng Wu, 2012, Human gene therapy.

Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidine.

S. Musser, C. Perno, J. Kelley, 1993, Drug metabolism and disposition: the biological fate of chemicals.